Pharmacokinetics Studies

Understanding Drug Absorption, Distribution, Metabolism, and Excretion

Pharmacokinetic studies are designed to evaluate how a substance behaves within a biological system over time. These evaluations support both safety assessment and product development by providing information on the absorption, distribution, metabolism, and excretion (ADME) profile of drugs, chemicals, and other test substances.

Our laboratory conducts pharmacokinetic studies within a scientifically controlled framework, compliant with OECD Good Laboratory Practice (GLP) principles when required, ensuring the generation of accurate, traceable, and regulatory-compliant data.

Role of Pharmacokinetics in Product Development

Understanding the biological fate of a substance is essential for determining exposure levels, dosing strategies, and potential toxicological risks. Pharmacokinetic data supports decision-making throughout the development process by helping to:

Characterize systemic exposure
Evaluate bioavailability and absorption profiles
Determine metabolic pathways
Assess elimination kinetics
Support dose selection and safety margins

These studies are a key component of non-clinical development programs and regulatory safety assessments.

Integration with Toxicology and Safety Programs

Pharmacokinetic studies are frequently integrated with toxicological evaluations to better understand the relationship between exposure and biological response. This combined approach supports:

Interpretation of toxicology findings
Determination of target organ exposure
Risk assessment and safety evaluation
Regulatory justification of study design

By correlating exposure data with toxicological outcomes, sponsors can establish more reliable safety profiles for their products.

GLP-Compliant Data Generation

When performed under GLP conditions, pharmacokinetic studies follow controlled protocols, validated procedures, and independent Quality Assurance oversight. This ensures: